These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38754594)

  • 21. Combination effect of physical and gustatory taste masking for propiverine hydrochloride orally disintegrating tablets on palatability.
    Matsui R; Uchida S; Namiki N
    Biol Pharm Bull; 2015; 38(1):17-22. PubMed ID: 25744453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of Prosolv and Prosolv:Mannitol 200 direct compression fillers on the physicomechanical properties of atorvastatin oral dispersible tablets.
    Gowda V; Pabari RM; Kelly JG; Ramtoola Z
    Pharm Dev Technol; 2015 Jun; 20(4):394-400. PubMed ID: 24397821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and evaluation of orally disintegrating tablets (ODTs) containing Ibuprofen granules prepared by hot melt extrusion.
    Gryczke A; Schminke S; Maniruzzaman M; Beck J; Douroumis D
    Colloids Surf B Biointerfaces; 2011 Sep; 86(2):275-84. PubMed ID: 21592751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigating the Impact of Co-processed Excipients on the Formulation of Bromhexine Hydrochloride Orally Disintegrating Tablets (ODTs).
    Woyna-Orlewicz K; Brniak W; Tatara W; Strzebońska M; Haznar-Garbacz D; Szafraniec-Szczęsny J; Antosik-Rogóż A; Wojteczko K; Strózik M; Kurek M; Jachowicz R; Mendyk A
    Pharm Res; 2023 Dec; 40(12):2947-2962. PubMed ID: 37726407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of co-processed excipients used for direct compression of orally disintegrating tablets (ODT) using novel disintegration apparatus.
    Brniak W; Jachowicz R; Krupa A; Skorka T; Niwinski K
    Pharm Dev Technol; 2013; 18(2):464-74. PubMed ID: 22881600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation and evaluation of orally disintegrating tablets of taste masked phencynonate HCl using ion-exchange resin.
    Ge Z; Yang M; Wang Y; Shan L; Gao C
    Drug Dev Ind Pharm; 2015 Jun; 41(6):934-41. PubMed ID: 24785576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of a quality-by-design approach for utilizing sodium stearyl fumarate as a taste-masking agent in dextromethorphan hydrobromide orally disintegrating tablets.
    Mahrous GM; Ibrahim MA; Mostafa HF; Elzayat EM
    Pharm Dev Technol; 2019 Jul; 24(6):711-719. PubMed ID: 30714850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safe, swallowable and palatable paediatric mini-tablet formulations for a WHO model list of essential medicines for children compound - A promising starting point for future PUMA applications.
    Freerks L; Sommerfeldt J; Löper PC; Klein S
    Eur J Pharm Biopharm; 2020 Nov; 156():11-19. PubMed ID: 32871197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins.
    Samprasit W; Akkaramongkolporn P; Ngawhirunpat T; Rojanarata T; Opanasopit P
    Drug Dev Ind Pharm; 2015 Jun; 41(6):1006-16. PubMed ID: 24865111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Taste-masked orodispersible tablets of cyclosporine self-nanoemulsion lyophilized with dry silica.
    Zidan AS; Aljaeid BM; Mokhtar M; Shehata TM
    Pharm Dev Technol; 2015; 20(6):652-61. PubMed ID: 25069592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a novel direct compressible co-processed excipient and its application for formulation of Mirtazapine orally disintegrating tablets.
    Loke YH; Chew YL; Janakiraman AK; Lee SK; Uddin ABMH; Goh CF; Kee PE; Ng HS; Ming LC; Liew KB
    Drug Dev Ind Pharm; 2024 Jan; 50(1):36-44. PubMed ID: 38149637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Citric Acid Suppresses the Bitter Taste of Olopatadine Hydrochloride Orally Disintegrating Tablets.
    Sotoyama M; Uchida S; Tanaka S; Hakamata A; Odagiri K; Inui N; Watanabe H; Namiki N
    Biol Pharm Bull; 2017; 40(4):451-457. PubMed ID: 28381800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and optimization of levodopa and benzylhydrazine orally disintegrating tablets by direct compression and response surface methodology.
    Zhang Y; Li Z; Tang H; Ren W; Gao X; Sun Y; Zhao QX; Wang F; Liu J
    Drug Dev Ind Pharm; 2020 Jan; 46(1):42-49. PubMed ID: 31794271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of co-processed excipient type on properties of orodispersible tablets containing captopril, tramadol, and domperidone.
    Tranová T; Loskot J; Navrátil O; Brniak W; Mužíková J
    Int J Pharm; 2023 Apr; 636():122838. PubMed ID: 36921743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and characterization of metformin hydrochloride- and glyburide-containing orally disintegrating tablets.
    Gulsun T; Akdag Y; Izat N; Cetin M; Oner L; Sahin S
    Pharm Dev Technol; 2020 Oct; 25(8):999-1009. PubMed ID: 32431206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of granule properties on rough mouth feel and palatability of orally disintegrating tablets.
    Kimura S; Uchida S; Kanada K; Namiki N
    Int J Pharm; 2015 Apr; 484(1-2):156-62. PubMed ID: 25681720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets.
    Douroumis DD; Gryczke A; Schminke S
    AAPS PharmSciTech; 2011 Mar; 12(1):141-51. PubMed ID: 21181510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of
    Abbas S; Sherazi M; Khan A; Alyami HS; Latif M; Qureshi ZU; Majeedullah ; Asad MHHB
    Biomed Res Int; 2021; 2021():5538075. PubMed ID: 34235217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formulation and evaluation of Cetirizine dihydrochloride orodispersible tablet.
    Subramanian S; Sankar V; Manakadan AA; Ismail S; Andhuvan G
    Pak J Pharm Sci; 2010 Apr; 23(2):232-5. PubMed ID: 20363705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex.
    Kim JI; Cho SM; Cui JH; Cao QR; Oh E; Lee BJ
    Int J Pharm; 2013 Oct; 455(1-2):31-9. PubMed ID: 23933050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.